SUNFLOWER(SZ:300111) Zhong Guo Jing Ji Wang·2025-09-08 01:13Core Viewpoint - The company Sunflower (300111.SZ) announced a significant asset restructuring plan involving the acquisition of controlling stakes in Zhangzhou Xipu Material Technology Co., Ltd. and 40% of Zhejiang Beid Pharmaceutical Co., Ltd. [1][2] Group 1: Asset Restructuring Details - The company plans to acquire the controlling stake in Xipu Material through the issuance of shares and/or cash payments [2] - The acquisition of 40% of Beid Pharmaceutical will also be conducted through share issuance [2] - The final valuation of both Xipu Material and Beid Pharmaceutical has not yet been determined, and the transaction is expected to be classified as a major asset restructuring under relevant regulations [1][2] Group 2: Stock Suspension and Disclosure - The company's stock will be suspended from trading starting September 8, 2025, to ensure fair information disclosure and protect investor interests [1] - The company anticipates disclosing the transaction plan within 10 trading days following the suspension [1]